Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making-Reference-Cited by-同舟云学术

Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making

Published:2024-03-06 Issue:5 Volume:47 Page:495-511
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Wessel Didrik,Pogrebnyakov Nicolai

Funder

Copenhagen Business School

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40264-024-01409-5.pdf

Reference84 articles.

1. Hoppe C, Kerr D. Minority underrepresentation in cardiovascular outcome trials for type 2 diabetes. Lancet Diabetes Endocrinol. 2017;5:13.

2. Morgan J, Feghali K, Shah S, Miranda W. RWE focus is shifting to R&D, early investments begin to pay off. How can others catch up? 2020. https://www2.deloitte.com/content/dam/insights/us/articles/6578_CHS-RWE-benchmarking-survey/DI_RWE%20benchmarking%20survey%20(SECURED).pdf. Accessed 21 Feb 2024.

3. US FDA. Framework for FDA’s real world evidence program. 2018. Available from: https://www.fda.gov/media/120060/download. Accessed 24 Jan 2023.

4. Shen N-N, Zhang C, Hang Y, Li Z, Kong L-C, Wang N, et al. Real-world prevalence of direct oral anticoagulant off-label doses in atrial fibrillation: an epidemiological meta-analysis. Front Pharmacol. 2021;12: 581293.

5. The Economist. How health care is turning into a consumer product. 2022. https://www.economist.com/business/how-health-care-is-turning-into-a-consumer-product/21807114. Accessed 29 Dec 2022.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction to: Using Social Media as a Source of Real‑World Data for Pharmaceutical Drug Development and Regulatory Decision Making;Drug Safety;2024-06-14